The DOI matches its Crossref record; 469 of the 469 references it cites were found in a registry or an index.
The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond
Open accessAbstract
The tumor necrosis factor (TNF) and TNF receptor (TNFR) superfamilies (TNFSF/TNFRSF) include 19 ligands and 29 receptors that play important roles in the modulation of cellular functions. The communication pathways mediated by TNFSF/TNFRSF are essential for numerous developmental, homeostatic, and stimulus-responsive processes in vivo. TNFSF/TNFRSF members regulate cellular differentiation, survival, and programmed death, but their most critical functions pertain to the immune system. Both innate and adaptive immune cells are controlled by TNFSF/TNFRSF members in a manner that is crucial for the coordination of various mechanisms driving either co-stimulation or co-inhibition of the immune response. Dysregulation of these same signaling pathways has been implicated in inflammatory and autoimmune diseases, highlighting the importance of their tight regulation. Investigation of the control of TNFSF/TNFRSF activities has led to the development of therapeutics with the potential to reduce chronic inflammation or promote anti-tumor immunity. The study of TNFSF/TNFRSF proteins has exploded over the last 30 yr, but there remains a need to better understand the fundamental mechanisms underlying the molecular pathways they mediate to design more effective anti-inflammatory and anti-cancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–400 of 469
Chen, X., Subleski, J. J., Kopf, H., Howard, O. M. Z., Männel, D. N., & Oppenheim, J. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6467 · Cited by 335
Josien, R., Li, H.-L., Ingulli, E., Sarma, S., R.Wong, B., Vologodskaia, M., Steinman, R. M., & Choi, Y. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.3.495 · Cited by 334
Stranges, P. B., Watson, J., Cooper, C. J., Choisy-Rossi, C.-M., Stonebraker, A. C., Beighton, R. A., Hartig, H., Sundberg, J. P., Servick, S., Kaufmann, G., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.03.016 · Cited by 334
The mouse fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster
Lynch, D. H., Watson, M. L., Alderson, M. R., Baum, P. R., Miller, R. E., Tough, T., Gibson, M., Davis-Smith, T., Smiths, C. A., Hunter, K., et al. (1994) · Immunity · doi:10.1016/1074-7613(94)90106-6 · Cited by 331
Intrinsic Lymphotoxin-β Receptor Requirement for Homeostasis of Lymphoid Tissue Dendritic Cells
Kabashima, K., Banks, T. A., Ansel, K. M., Lu, T. T., Ware, C. F., & Cyster, J. G. (2005) · Immunity · doi:10.1016/j.immuni.2005.02.007 · Cited by 327
Biophysical mechanism of T-cell receptor triggering in a reconstituted system
James, J. R., & Vale, R. D. (2012) · Nature · doi:10.1038/nature11220 · Cited by 323
Kopf, M., Ruedl, C., Schmitz, N., Gallimore, A., Lefrang, K., Ecabert, B., Odermatt, B., & Bachmann, M. F. (1999) · Immunity · doi:10.1016/s1074-7613(00)80144-2 · Cited by 321
RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis
Takahashi, N., Vereecke, L., Bertrand, M. J. M., Duprez, L., Berger, S. B., Divert, T., Gonçalves, A., Sze, M., Gilbert, B., Kourula, S., et al. (2014) · Nature · doi:10.1038/nature13706 · Cited by 318
Fas engagement induces neurite growth through ERK activation and p35 upregulation
Desbarats, J., Birge, R. B., Mimouni-Rongy, M., Weinstein, D. E., Palerme, J.-S., & Newell, M. K. (2003) · Nature Cell Biology · doi:10.1038/ncb916 · Cited by 312
Gattorno, M., Pelagatti, M. A., Meini, A., Obici, L., Barcellona, R., Federici, S., Buoncompagni, A., Plebani, A., Merlini, G., & Martini, A. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23475 · Cited by 312
Antitumor effect of locally produced CD95 ligand
Seino, K.-I., Kayagaki, N., Okumura, K., & Yagita, H. (1997) · Nature Medicine · doi:10.1038/nm0297-165 · Cited by 312
Yan, M., Wang, L.-C., Hymowitz, S. G., Schilbach, S., Lee, J., Goddard, A., de Vos, A. M., Gao, W.-Q., & Dixit, V. M. (2000) · Science · doi:10.1126/science.290.5491.523 · Cited by 311
Yes and PI3K Bind CD95 to Signal Invasion of Glioblastoma
Kleber, S., Sancho-Martinez, I., Wiestler, B., Beisel, A., Gieffers, C., Hill, O., Thiemann, M., Mueller, W., Sykora, J., Kuhn, A., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.003 · Cited by 309
Self-citationRANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers
Nolan, E., Vaillant, F., Branstetter, D., Pal, B., Giner, G., Whitehead, L., Lok, S. W., Mann, G. B., Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab), Rohrbach, K., et al. (2016) · Nature Medicine · doi:10.1038/nm.4118 · Cited by 309
Distinct Roles for the OX40-OX40 Ligand Interaction in Regulatory and Nonregulatory T Cells
Takeda, I., Ine, S., Killeen, N., Ndhlovu, L. C., Murata, K., Satomi, S., Sugamura, K., & Ishii, N. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3580 · Cited by 308
Isenberg, D., Gordon, C., Licu, D., Copt, S., Rossi, C. P., Wofsy, D., Babini, A., Lazaro, M., Lucero, E., Merono, C., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-205067 · Cited by 306
Impaired Negative Selection of T Cells in Hodgkin's Disease Antigen CD30–Deficient Mice
Amakawa, R., Hakem, A., Kundig, T. M., Matsuyama, T., Simard, J. J. L., Timms, E., Wakeham, A., Mittruecker, H.-W., Griesser, H., Takimoto, H., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81031-4 · Cited by 305
A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.
Sneller, M. C., Straus, S. E., Jaffe, E. S., Jaffe, J. S., Fleisher, T. A., Stetler-Stevenson, M., & Strober, W. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115867 · Cited by 301
Smahi, A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.20.2371 · Cited by 300
Bamias, G., Martin, C., Marini, M., Hoang, S., Mishina, M., Ross, W. G., Sachedina, M. A., Friel, C. M., Mize, J., Bickston, S. J., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.9.4868 · Cited by 299
Immune regulation by 4‐1BB and 4‐1BBL: complexities and challenges
Wang, C., Lin, G. H. Y., McPherson, A. J., & Watts, T. H. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00765.x · Cited by 298
Identification and functional characterization of DR6, a novel death domain‐containing TNF receptor
Pan, G., Bauer, J. H., Haridas, V., Wang, S., Liu, D., Yu, G., Vincenz, C., Aggarwal, B. B., Ni, J., & Dixit, V. M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00791-1 · Cited by 291
Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases
Croft, M., & Siegel, R. M. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.22 · Cited by 288
Signaling by the tumor necrosis factor receptor superfamily in B‐cell biology and disease
Rickert, R. C., Jellusova, J., & Miletic, A. V. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01067.x · Cited by 285
Kanamaru, F., Youngnak, P., Hashiguchi, M., Nishioka, T., Takahashi, T., Sakaguchi, S., Ishikawa, I., & Azuma, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7306 · Cited by 285
CD95 ligand induces motility and invasiveness of apoptosis‐resistant tumor cells
Barnhart, B. C., Legembre, P., Pietras, E., Bubici, C., Franzoso, G., & Peter, M. E. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600325 · Cited by 284
c-FLIPR, a New Regulator of Death Receptor-induced Apoptosis
Golks, A., Brenner, D., Fritsch, C., Krammer, P. H., & Lavrik, I. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414425200 · Cited by 282
Self-citationMahmud, S. A., Manlove, L. S., Schmitz, H. M., Xing, Y., Wang, Y., Owen, D. L., Schenkel, J. M., Boomer, J. S., Green, J. M., Yagita, H., et al. (2014) · Nature Immunology · doi:10.1038/ni.2849 · Cited by 281
Ermolaeva, M. A., Michallet, M.-C., Papadopoulou, N., Utermöhlen, O., Kranidioti, K., Kollias, G., Tschopp, J., & Pasparakis, M. (2008) · Nature Immunology · doi:10.1038/ni.1638 · Cited by 281
Structural principles of tumor necrosis factor superfamily signaling
Vanamee, É. S., & Faustman, D. L. (2018) · Science Signaling · doi:10.1126/scisignal.aao4910 · Cited by 280
Ubiquitination of RIP Is Required for Tumor Necrosis Factor α-induced NF-κB Activation
Li, H., Kobayashi, M., Blonska, M., You, Y., & Lin, X. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600620200 · Cited by 277
The Fas–FADD death domain complex structure reveals the basis of DISC assembly and disease mutations
Wang, L., Yang, J. K., Kabaleeswaran, V., Rice, A. J., Cruz, A. C., Park, A. Y., Yin, Q., Damko, E., Jang, S. B., Raunser, S., et al. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1920 · Cited by 276
Ehrhardt, H., Fulda, S., Schmid, I., Hiscott, J., Debatin, K.-M., & Jeremias, I. (2003) · Oncogene · doi:10.1038/sj.onc.1206520 · Cited by 272
Xu, S., & Lam, K.-P. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.12.4067-4074.2001 · Cited by 267
Chen, W., Zhou, Z., Li, L., Zhong, C.-Q., Zheng, X., Wu, X., Zhang, Y., Ma, H., Huang, D., Li, W., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.435545 · Cited by 266
Nonredundant Function of Soluble LTα 3 Produced by Innate Lymphoid Cells in Intestinal Homeostasis
Kruglov, A. A., Grivennikov, S. I., Kuprash, D. V., Winsauer, C., Prepens, S., Seleznik, G. M., Eberl, G., Littman, D. R., Heikenwalder, M., Tumanov, A. V., et al. (2013) · Science · doi:10.1126/science.1243364 · Cited by 262
Scheu, S., Alferink, J., Pötzel, T., Barchet, W., Kalinke, U., & Pfeffer, K. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020215 · Cited by 260
Takedatsu, H., Michelsen, K. S., Wei, B., Landers, C. J., Thomas, L. S., Dhall, D., Braun, J., & Targan, S. R. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.037 · Cited by 254
Jones, E. Y., Mongkolsapaya, J., Grimes, J. M., Chen, N., Xu, X., Stuart, D. I., & Screaton, G. R. (1999) · Nature Structural Biology · doi:10.1038/14935 · Cited by 253
Gene transfer of Fas ligand induces tumor regression in vivo
Arai, H., Gordon, D., Nabel, E. G., & Nabel, G. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13862 · Cited by 248
Lack of a Role for Jun Kinase and AP-1 in Fas-Induced Apoptosis
Lenczowski, J. M., Domínguez, L., Eder, A. M., King, L. B., Zacharchuk, C. M., & Ashwell, J. D. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.170 · Cited by 245
Death Receptor-Ligand Systems in Cancer, Cell Death, and Inflammation
Walczak, H. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008698 · Cited by 242
Fas engagement accelerates liver regeneration after partial hepatectomy
Desbarats, J., & Newell, M. K. (2000) · Nature Medicine · doi:10.1038/78688 · Cited by 241
Vince, J. E., Pantaki, D., Feltham, R., Mace, P. D., Cordier, S. M., Schmukle, A. C., Davidson, A. J., Callus, B. A., Wong, W. W.-L., Gentle, I. E., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.072256 · Cited by 241
Arens, R., Tesselaar, K., Baars, P. A., van Schijndel, G. M. W., Hendriks, J., Pals, S. T., Krimpenfort, P., Borst, J., van Oers, M. H. J., & van Lier, R. A. W. (2001) · Immunity · doi:10.1016/s1074-7613(01)00236-9 · Cited by 239
Castigli, E., Alt, F. W., Davidson, L., Bottaro, A., Mizoguchi, E., Bhan, A. K., & Geha, R. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12135 · Cited by 238
Akiba, H., Miyahira, Y., Atsuta, M., Takeda, K., Nohara, C., Futagawa, T., Matsuda, H., Aoki, T., Yagita, H., & Okumura, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.375 · Cited by 233
Shaikh, R. B., Santee, S., Granger, S. W., Butrovich, K., Cheung, T., Kronenberg, M., Cheroutre, H., & Ware, C. F. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6330 · Cited by 230
Lobito, A. A., Kimberley, F. C., Muppidi, J. R., Komarow, H., Jackson, A. J., Hull, K. M., Kastner, D. L., Screaton, G. R., & Siegel, R. M. (2006) · Blood · doi:10.1182/blood-2005-11-006783 · Cited by 229
Pop, C., Oberst, A., Drag, M., Van Raam, B. J., Riedl, S. J., Green, D. R., & Salvesen, G. S. (2011) · Biochemical Journal · doi:10.1042/bj20101738 · Cited by 226
The TNF-Family Receptor DR3 is Essential for Diverse T Cell-Mediated Inflammatory Diseases
Meylan, F., Davidson, T. S., Kahle, E., Kinder, M., Acharya, K., Jankovic, D., Bundoc, V., Hodges, M., Shevach, E. M., Keane-Myers, A., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.04.021 · Cited by 223
Solution of the Structure of the TNF-TNFR2 Complex
Mukai, Y., Nakamura, T., Yoshikawa, M., Yoshioka, Y., Tsunoda, S.-I., Nakagawa, S., Yamagata, Y., & Tsutsumi, Y. (2010) · Science Signaling · doi:10.1126/scisignal.2000954 · Cited by 221
Regulation of cell surface APO‐1/Fas (CD95) ligand expression by metalloproteases
Mariani, S. M., Matiba, B., Bäumler, C., & Krammer, P. H. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250828 · Cited by 217
Pobezinskaya, Y. L., Kim, Y.-S., Choksi, S., Morgan, M. J., Li, T., Liu, C., & Liu, Z. (2008) · Nature Immunology · doi:10.1038/ni.1639 · Cited by 216
Girgenrath, M., Weng, S., Kostek, C. A., Browning, B., Wang, M., Brown, S. A., Winkles, J. A., Michaelson, J. S., Allaire, N., Schneider, P., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601441 · Cited by 213
Becher, B., Durell, B. G., Miga, A. V., Hickey, W. F., & Noelle, R. J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.8.967 · Cited by 213
Fas Receptor Expression in Germinal-Center B Cells Is Essential for T and B Lymphocyte Homeostasis
Hao, Z., Duncan, G. S., Seagal, J., Su, Y.-W., Hong, C., Haight, J., Chen, N.-J., Elia, A., Wakeham, A., Li, W. Y., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.07.016 · Cited by 212
Hendriks, J., Xiao, Y., Rossen, J. W. A., van der Sluijs, K. F., Sugamura, K., Ishii, N., & Borst, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1665 · Cited by 212
Molecular aspects of hypohidrotic ectodermal dysplasia
Mikkola, M. L. (2009) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32855 · Cited by 212
Permanent correction of an inherited ectodermal dysplasia with recombinant EDA
Gaide, O., & Schneider, P. (2003) · Nature Medicine · doi:10.1038/nm861 · Cited by 211
Jember, A. G.-H., Zuberi, R., Liu, F.-T., & Croft, M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.3.387 · Cited by 210
TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses
Burkly, L. C., Michaelson, J. S., & Zheng, T. S. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01054.x · Cited by 208
The costimulation-regulated duration of PKB activation controls T cell longevity
Song, J., Salek-Ardakani, S., Rogers, P. R., Cheng, M., Van Parijs, L., & Croft, M. (2004) · Nature Immunology · doi:10.1038/ni1030 · Cited by 207
Src kinase phosphorylates Caspase‐8 on Tyr380: a novel mechanism of apoptosis suppression
Cursi, S., Rufini, A., Stagni, V., Condò, I., Matafora, V., Bachi, A., Bonifazi, A. P., Coppola, L., Superti‐Furga, G., Testi, R., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601085 · Cited by 205
Zheng, C., Kabaleeswaran, V., Wang, Y., Cheng, G., & Wu, H. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.03.009 · Cited by 205
Iezzi, G., Sonderegger, I., Ampenberger, F., Schmitz, N., Marsland, B. J., & Kopf, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810769106 · Cited by 203
Remijsen, Q., Goossens, V, Grootjans, S., Van den Haute, C., Vanlangenakker, N., Dondelinger, Y., Roelandt, R., Bruggeman, I., Goncalves, A., Bertrand, M. J. M., et al. (2014) · Cell Death & Disease · doi:10.1038/cddis.2013.531 · Cited by 202
Kawamata, S., Hori, T., Imura, A., Takaori-Kondo, A., & Uchiyama, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5808 · Cited by 200
Tumanov, A. V., Koroleva, E. P., Guo, X., Wang, Y., Kruglov, A., Nedospasov, S., & Fu, Y.-X. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.06.002 · Cited by 199
GENETIC DISORDERS OF PROGRAMMED CELL DEATH IN THE IMMUNE SYSTEM
Bidère, N., Su, H. C., & Lenardo, M. J. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090513 · Cited by 197
Role of CD27/CD70 pathway of activation in immunity and tolerance
Denoeud, J., & Moser, M. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0610351 · Cited by 197
Notley, C. A., Inglis, J. J., Alzabin, S., McCann, F. E., McNamee, K. E., & Williams, R. O. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072707 · Cited by 196
Simon, A., Park, H., Maddipati, R., Lobito, A. A., Bulua, A. C., Jackson, A. J., Chae, J. J., Ettinger, R., de Koning, H. D., Cruz, A. C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914118107 · Cited by 196
TRAF Proteins in CD40 Signaling
Bishop, G. A., Moore, C. R., Xie, P., Stunz, L. L., & Kraus, Z. J. (2007) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-70630-6_11 · Cited by 194
Multiple signaling pathways promote B lymphocyte stimulator–dependent B-cell growth and survival
Woodland, R. T., Fox, C. J., Schmidt, M. R., Hammerman, P. S., Opferman, J. T., Korsmeyer, S. J., Hilbert, D. M., & Thompson, C. B. (2008) · Blood · doi:10.1182/blood-2007-03-077222 · Cited by 193
Park, Y. C., Ye, H., Hsia, C., Segal, D., Rich, R. L., Liou, H.-C., Myszka, D. G., & Wu, H. (2000) · Cell · doi:10.1016/s0092-8674(00)80889-2 · Cited by 190
Vlantis, K., Wullaert, A., Polykratis, A., Kondylis, V., Dannappel, M., Schwarzer, R., Welz, P., Corona, T., Walczak, H., Weih, F., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.020 · Cited by 189
Targeting B-Cell Maturation Antigen in Multiple Myeloma
Tai, Y.-T., & Anderson, K. C. (2015) · Immunotherapy · doi:10.2217/imt.15.77 · Cited by 188
The coevolution of gene family trees
Fryxell, K. J. (1996) · Trends in Genetics · doi:10.1016/s0168-9525(96)80020-5 · Cited by 187
Hughes, M. A., Harper, N., Butterworth, M., Cain, K., Cohen, G. M., & MacFarlane, M. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.06.012 · Cited by 185
Cachetin/TNF-α in Septic Shock and Septic Adult Respiratory Distress Syndrome
Tracey, K. J., Lowry, S. F., & Cerami, A. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/138.6.1377 · Cited by 185
Fas–Fas Ligand: Checkpoint of T Cell Functions in Multiple Sclerosis
Volpe, E., Sambucci, M., Battistini, L., & Borsellino, G. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00382 · Cited by 185
Demyelination and other neurological adverse events after anti-TNF therapy
Kaltsonoudis, E., Voulgari, P. V., Konitsiotis, S., & Drosos, A. A. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.09.002 · Cited by 184
Caspases: cellular demolition experts
Creagh, E. M., & Martin, S. J. (2001) · Biochemical Society Transactions · doi:10.1042/0300-5127:0290696 · Cited by 184
Nguyen, D. X., & Ehrenstein, M. R. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151255 · Cited by 184
Torrey, H., Butterworth, J., Mera, T., Okubo, Y., Wang, L., Baum, D., Defusco, A., Plager, S., Warden, S., Huang, D., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aaf8608 · Cited by 182
Tumor Necrosis Factor–Like Weak Inducer of Apoptosis Is a Mitogen for Liver Progenitor Cells
Tirnitz-Parker, J. E. E., Viebahn, C. S., Jakubowski, A., Klopcic, B. R. S., Olynyk, J. K., Yeoh, G. C. T., & Knight, B. (2010) · Hepatology · doi:10.1002/hep.23663 · Cited by 177
RANKL/RANK control Brca1 mutation-driven mammary tumors
Sigl, V., Owusu-Boaitey, K., Joshi, P. A., Kavirayani, A., Wirnsberger, G., Novatchkova, M., Kozieradzki, I., Schramek, D., Edokobi, N., Hersl, J., et al. (2016) · Cell Research · doi:10.1038/cr.2016.69 · Cited by 175
The Drosophila TNF receptor Grindelwald couples loss of cell polarity and neoplastic growth
Andersen, D. S., Colombani, J., Palmerini, V., Chakrabandhu, K., Boone, E., Röthlisberger, M., Toggweiler, J., Basler, K., Mapelli, M., Hueber, A.-O., et al. (2015) · Nature · doi:10.1038/nature14298 · Cited by 174
Ferguson, B. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.9.1589 · Cited by 172
TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties
Mackay, F., & Schneider, P. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.04.006 · Cited by 171
CD27 Signaling Increases the Frequency of Regulatory T Cells and Promotes Tumor Growth
Claus, C., Riether, C., Schürch, C., Matter, M. S., Hilmenyuk, T., & Ochsenbein, A. F. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2791 · Cited by 168
Kim, I.-K., Kim, B.-S., Koh, C.-H., Seok, J.-W., Park, J.-S., Shin, K.-S., Bae, E.-A., Lee, G.-E., Jeon, H., Cho, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3922 · Cited by 167
Essential protective role of tumor necrosis factor receptor 2 in neurodegeneration
Dong, Y., Fischer, R., Naudé, P. J. W., Maier, O., Nyakas, C., Duffey, M., Van der Zee, E. A., Dekens, D., Douwenga, W., Herrmann, A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1605195113 · Cited by 166
Role of GITR in activation response of T lymphocytes
Ronchetti, S., Nocentini, G., Riccardi, C., & Pandolfi, P. P. (2002) · Blood · doi:10.1182/blood-2001-12-0276 · Cited by 165
Structure of the human APO‐1 gene
Behrmann, I., Walczak, H., & Krammer, P. H. (1994) · European Journal of Immunology · doi:10.1002/eji.1830241221 · Cited by 165
Coquet, J. M., Ribot, J. C., Bąbała, N., Middendorp, S., van der Horst, G., Xiao, Y., Neves, J. F., Fonseca-Pereira, D., Jacobs, H., Pennington, D. J., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20112061 · Cited by 164
TRAIL receptor signaling and therapeutics
Abdulghani, J., & El‐Deiry, W. S. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.519701 · Cited by 161
Ota, N., Wong, K., Valdez, P. A., Zheng, Y., Crellin, N. K., Diehl, L., & Ouyang, W. (2011) · Nature Immunology · doi:10.1038/ni.2089 · Cited by 160
Fas/Apo-1(CD95) expression and apoptosis in patients with myelodysplastic syndromes
Bouscary, D., De Vos, J., Guesnu, M., Jondeau, K., Viguier, F., Melle, J., Picard, F., Dreyfus, F., & Fontenay-Roupie, M. (1997) · Leukemia · doi:10.1038/sj.leu.2400654 · Cited by 159
OX40–OX40 Ligand Interaction in T-Cell-Mediated Immunity and Immunopathology
Ishii, N., Takahashi, T., Soroosh, P., & Sugamura, K. (2010) · Advances in immunology · doi:10.1016/s0065-2776(10)05003-0 · Cited by 158
Nagar, M., Jacob‐Hirsch, J., Vernitsky, H., Berkun, Y., Ben‐Horin, S., Amariglio, N., Bank, I., Kloog, Y., Rechavi, G., & Goldstein, I. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902070 · Cited by 156
Claessens, Y.-É., Bouscary, D., Dupont, J., Picard, F., Melle, J., Gisselbrecht, S., Lacombe, C., Dreyfus, F., Mayeux, P., & Fontenay, M. (2002) · Blood · doi:10.1182/blood.v99.5.1594 · Cited by 154
The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation
Meylan, F., Song, Y.-J., Fuss, I. J., Villarreal, S., Kahle, E., Malm, I.-J., Acharya, K., Ramos, H. L., Lo, L., Mentink‐Kane, M. M., et al. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.67 · Cited by 154
Origin and evolution of TNF and TNF receptor superfamilies
Wiens, G. D., & Glenney, G. W. (2011) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2011.03.031 · Cited by 154
Wang, Y., Koroleva, E. P., Kruglov, A., Kuprash, D. V., Nedospasov, S. A., Fu, Y., & Tumanov, A. V. (2010) · Immunity · doi:10.1016/j.immuni.2010.02.011 · Cited by 154
Concepts of activated T cell death
Brenner, D., Krammer, P. H., & Arnold, R. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.01.002 · Cited by 153
Self-citationArens, R., Schepers, K., Nolte, M. A., van Oosterwijk, M. F., van Lier, R. A. W., Schumacher, T. N., & van Oers, M. H. J. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031111 · Cited by 153
Brandt, S. M., Dionne, M., Khush, R. S., Pham, L. N., Vigdal, T. J., & Schneider, D. S. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020418 · Cited by 152
4-1BB signaling beyond T cells
Vinay, D. S., & Kwon, B. S. (2011) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.82 · Cited by 149
Qamar, N., & Fuleihan, R. (2013) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-013-8378-7 · Cited by 149
Toyoshima, F., Moriguchi, T., & Nishida, E. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.4.1005 · Cited by 148
Schneider, K., Loewendorf, A. I., Trez, C. D., Fulton, J., Rhode, A., Shumway, H. M., Ha, S., Patterson, G., Pfeffer, K., Nedospasov, S. A., et al. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2007.12.008 · Cited by 148
Hoogwater, F. J. H., Nijkamp, M. W., Smakman, N., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.02.046 · Cited by 147
Lymphotoxin regulates commensal responses to enable diet-induced obesity
Upadhyay, V., Poroyko, V. A., Kim, T.-J., Devkota, S., Fu, S., Liu, D., Tumanov, A. V., Koroleva, E. P., Deng, L., Nagler‐Anderson, C., et al. (2012) · Nature Immunology · doi:10.1038/ni.2403 · Cited by 147
Fas Involvement in Cytotoxicity Mediated by Human NK Cells
Montel, A. H., Bochan, M. R., Hobbs, J. A., Lynch, D. H., & Brahmi, Z. (1995) · Cellular Immunology · doi:10.1006/cimm.1995.9974 · Cited by 146
Crockett, J. C., Mellis, D. J., Scott, D. I., & Helfrich, M. H. (2011) · Osteoporosis International · doi:10.1007/s00198-010-1272-8 · Cited by 143
OX40: Structure and function – What questions remain?
Willoughby, J. E., Griffiths, J., Tews, I., & Cragg, M. S. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.01.006 · Cited by 143
van Gisbergen, K. P. J. M., Klarenbeek, P. L., Kragten, N. A. M., Unger, P. A., Nieuwenhuis, M. B. B., Wensveen, F. M., ten Brinke, A., Tak, P. P., Eldering, E., Nolte, M. A., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.04.020 · Cited by 142
Hao, Z., Hampel, B., Yagita∥, H., & Rajewsky, K. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20032196 · Cited by 140
So, T., & Croft, M. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00139 · Cited by 139
A co-evolution perspective of the TNFSF and TNFRSF families in the immune system
Collette, Y., Gilles, A., Pontarotti, P., & Olive, D. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00166-2 · Cited by 139
Lymphotoxin signalling in immune homeostasis and the control of microorganisms
Upadhyay, V., & Fu, Y. (2013) · Nature reviews. Immunology · doi:10.1038/nri3406 · Cited by 137
Implication of TNF-Related Apoptosis-Inducing Ligand in Inflammatory Intestinal Epithelial Lesions
Bègue, B., Wajant, H., Bambou, J., Dubuquoy, L., Siegmund, D., Beaulieu, J., Canioni, D., Berrebi, D. D., Brousse, N., Desreumaux, P., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.022 · Cited by 135
Wick, W., Fricke, H., Junge, K., Kobyakov, G., Martens, T., Heese, O., Wiestler, B., Schliesser, M. G., von Deimling, A., Pichler, J., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0951-t · Cited by 135
The Naturally Processed CD95L Elicits a c-Yes/Calcium/PI3K-Driven Cell Migration Pathway
Tauzin, S., Chaigne-Delalande, B., Selva, É., Khadra, N., Daburon, S., Contin‐Bordes, C., Blanco, P., Seyec, J. L., Ducret, T., Counillon, L., et al. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001090 · Cited by 132
Meylan, F., Richard, A. C., & Siegel, R. M. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01068.x · Cited by 132
The regulation and role of T follicular helper cells in immunity
Deenick, E. K., & Ma, C. S. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03487.x · Cited by 131
Letellier, E., Kumar, S., Sancho-Martinez, I., Krauth, S. J., Funke-Kaiser, A., Laudenklos, S., Konecki, K., Klußmann, S., Corsini, N. S., Kleber, S., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.01.011 · Cited by 128
Self-citationSessler, T., Healy, S., Samali, A., & Szegezdi, É. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.06.009 · Cited by 128
Matsuzawa, A., Moriyama, T., Kaneko, T., Tanaka, M., Kimura, M., Ikeda, H., & Katagiri, T. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.2.519 · Cited by 128
Effector T-cell subsets in systemic lupus erythematosus: update focusing on Th17 cells
Shin, M. S., Lee, N., & Kang, I. (2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328349a255 · Cited by 127
Functional Dichotomy between OX40 and 4-1BB in Modulating Effector CD8 T Cell Responses
Lee, S., Park, Y., Song, A., Cheroutre, H., Kwon, B. S., & Croft, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4464 · Cited by 120
Senft, J., Helfer, B. M., & Frisch, S. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-5755 · Cited by 120
Peperzak, V., Xiao, Y., Veraar, E. A. M., & Borst, J. G. (2009) · Journal of Clinical Investigation · doi:10.1172/jci40178 · Cited by 120
CD27-CD70 interactions sensitise naive CD4+ T cells for IL-12-induced Th1 cell development
van Oosterwijk, M. F., Juwana, H., Arens, R., Tesselaar, K., van Oers, M. H. J., Eldering, E., & van Lier, R. A. W. (2007) · International Immunology · doi:10.1093/intimm/dxm033 · Cited by 120
Structural Basis for the Lack of E2 Interaction in the RING Domain of TRAF2
Yin, Q., Lamothe, B., Darnay, B. G., & Wu, H. (2009) · Biochemistry · doi:10.1021/bi901462e · Cited by 119
Horn, S., Hughes, M. A., Schilling, R., Sticht, C., Tenev, T., Ploesser, M., Meier, P., Sprick, M. R., MacFarlane, M., & Leverkus, M. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.010 · Cited by 119
Control of neuronal branching by the death receptor CD95 (Fas/Apo-1)
Zuliani, C., Kleber, S., Klussmann, S., Wenger, T., Kenzelmann, M., Schreglmann, N., Martinez, A., del Rio, J. A., Soriano, E., Vodrazka, P., et al. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401720 · Cited by 117
Körner, H., Lemckert, F. A., Chaudhri, G., Etteldorf, S., & Sedgwick, J. D. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270822 · Cited by 117
OX40 ligand expressed by DCs costimulates NKT and CD4+ Th cell antitumor immunity in mice
Zaini, J., Andarini, S., Tahara, M., Saijo, Y., Ishii, N., Kawakami, K., Taniguchi, M., Sugamura, K., Nukiwa, T., & Kikuchi, T. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32693 · Cited by 117
Casal, M. L., Lewis, J. R., Mauldin, E. A., Tardivel, A., Ingold, K., Favre, M., Paradies, F., Demotz, S., Gaide, O., & Schneider, P. (2007) · The American Journal of Human Genetics · doi:10.1086/521988 · Cited by 116
Malleter, M., Tauzin, S., Bessede, A., Castellano, R., Goubard, A., Godey, F., Lévêque, J., Jézéquel, P., Campion, L., Campone, M., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1794 · Cited by 114
Drosophila eiger Mutants Are Sensitive to Extracellular Pathogens
Schneider, D. S., Ayres, J. S., Brandt, S. M., Costa, A. D. T., Dionne, M., Gordon, M. D., Mabery, E. M., Moule, M. G., Pham, L. N., & Shirasu‐Hiza, M. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030041 · Cited by 114
CD40/CD40L interaction regulates CD4+CD25+ T reg homeostasis through dendritic cell‐produced IL‐2
Guiducci, C., Valzasina, B., Dislich, H., & Colombo, M. P. (2005) · European Journal of Immunology · doi:10.1002/eji.200425810 · Cited by 113
Richard, A. C., Tan, C., Hawley, E., Gómez‐Rodríguez, J., Goswami, R., Yang, X., Cruz, A. C., Penumetcha, P., Hayes, E. T., Pelletier, M., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401220 · Cited by 112
Shinohara, H., Yagita∥, H., Ikawa, Y., & Oyaizu, N. (2000) · PubMed · Cited by 111
Role of tumor necrosis factor superfamily in neuroinflammation and autoimmunity
Sonar, S. A., & Lal, G. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00364 · Cited by 110
McCann, F. E., Perocheau, D. P. B., Ruspi, G., Blazek, K. D., Davies, M. L., Feldmann, M., Dean, J. L. E., Stoop, A. A., & Williams, R. O. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38755 · Cited by 110
Tumor Necrosis Factor Superfamily in Innate Immunity and Inflammation
Šedý, J., Bekiaris, V., & Ware, C. F. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016279 · Cited by 109
Coquet, J. M., Middendorp, S., Horst, G., Kind, J., Veraar, E. A. M., Xiao, Y., Jacobs, H., & Borst, J. G. (2012) · Immunity · doi:10.1016/j.immuni.2012.09.009 · Cited by 109
Tumour Necrosis Factor Superfamily Members in the Pathogenesis of Inflammatory Bowel Disease
Ślebioda, T. J., & Kmieć, Z. (2014) · Mediators of Inflammation · doi:10.1155/2014/325129 · Cited by 108
Association of lpr gene with graft-vs.-host disease-like syndrome.
Theofilopoulos, A. N., BALDERAS, R. S., Gozes, Y., Aguado, M. T., Hang, L. M., Morrow, P. R., & Dixon, F. J. (1985) · The Journal of Experimental Medicine · doi:10.1084/jem.162.1.1 · Cited by 108
Induction of apoptosis and activation of NF‐κB by CD95 require different signalling thresholds
Legembre, P., Barnhart, B. C., Zheng, L., Vijayan, S., Straus, S. E., Puck, J. M., Dale, J. K., Lenardo, M. J., & Peter, M. E. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400280 · Cited by 108
The promise of 4‐1BB (CD137)‐mediated immunomodulation and the immunotherapy of cancer
Lynch, D. H. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00621.x · Cited by 107
Diana, J., Griseri, T., Lagaye, S., Beaudoin, L., Autrusseau, E., Gautron, A.-S., Tomkiewicz, C., Herbelin, A., Barouki, R., von Herrath, M., et al. (2009) · Immunity · doi:10.1016/j.immuni.2008.12.017 · Cited by 107
Vaitla, P., Radford, P. M., Tighe, P. J., Powell, R. J., McDermott, E. M., Todd, I., & Drewe, E. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30215 · Cited by 103
The contextual role of TNFR family members in CD 8+ T‐cell control of viral infections
Wortzman, M. E., Clouthier, D., McPherson, A. J., Lin, G. H. Y., & Watts, T. H. (2013) · Immunological Reviews · doi:10.1111/imr.12086 · Cited by 102
Taraban, V. Y., Ślebioda, T. J., Willoughby, J. E., Buchan, S. L., James, S., Sheth, B., Smyth, N. R., Thomas, G. J., Wang, E. C. Y., & Al‐Shamkhani, A. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.70 · Cited by 102
Roos, C., Wicovsky, A., Müller, N., Salzmann, S., Rosenthal, T., Kalthoff, H., Trauzold, A., Seher, A., Henkler, F., Kneitz, C., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903555 · Cited by 98
Ectodysplasin A (EDA) – EDA receptor signalling and its pharmacological modulation
Kowalczyk-Quintas, C., & Schneider, P. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.01.004 · Cited by 97
Cell-specific and context-dependent effects of GITR in cancer, autoimmunity, and infection
Clouthier, D., & Watts, T. H. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.12.003 · Cited by 96
Fas Signal Transduction Triggers Either Proliferation or Apoptosis in Human Fibroblasts
Freiberg, R. A., Spencer, D. M., Choate, K. A., Duh, H. J., Schreiber, S. L., Crabtree, G. R., & Khavari, P. A. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12334273 · Cited by 95
Fas and TRAIL ‘death receptors’ as initiators of inflammation: Implications for cancer
Cullen, S. P., & Martin, S. J. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.01.012 · Cited by 94
The Drosophila TNF ortholog Eiger: Emerging physiological roles and evolution of the TNF system
Igaki, T., & Miura, M. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.05.003 · Cited by 93
Dichotomy between naïve and memory CD4 + T cell responses to Fas engagement
Desbarats, J., Wade, T. K., Wade, W. F., & Newell, M. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.8104 · Cited by 90
CD40-Mediated Activation of the NF-κB2 Pathway
Hostager, B. S., & Bishop, G. A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00376 · Cited by 90
Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelination
Mi, S., Lee, X., Hu, Y., Ji, B., Shao, Z., Yang, W., Huang, G., Walus, L. R., Rhodes, K. J., Gong, B. J., et al. (2011) · Nature Medicine · doi:10.1038/nm.2373 · Cited by 90
Poissonnier, A., Sanséau, D., Gallo, M. L., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.06.028 · Cited by 90
Autoinflammatory Diseases with Periodic Fevers
Sağ, E., Bilginer, Y., & Özen, S. (2017) · Current Rheumatology Reports · doi:10.1007/s11926-017-0670-8 · Cited by 86
Holtmann, M. H., Douni, E. K., Schütz, M., Zeller, G. C., Mudter, J., Lehr, H., Gerspach, J., Scheurich, P., Galle, P. R., Kollias, G. A., et al. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200211)32:11<3142::aid-immu3142>3.0.co;2-4 · Cited by 84
Mouri, Y., Yano, M., Shinzawa, M., Shimo, Y., Hirota, F., Nishikawa, Y., Nii, T., Kiyonari, H., Abe, T., Uehara, H., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003533 · Cited by 84
The CD27–CD70 pathway and pathogenesis of autoimmune disease
Han, B. K., Olsen, N. J., & Bottaro, A. (2015) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2015.08.001 · Cited by 83
Enhanced CD4+ T Cell Proliferation and Th2 Cytokine Production in DR6-Deficient Mice
Liu, J., Na, S., Glasebrook, A. L., Fox, N. W., Solenberg, P. J., Zhang, Q., Song, H. Y., & Yang, D. D. (2001) · Immunity · doi:10.1016/s1074-7613(01)00162-5 · Cited by 83
Zeiser, R., Nguyen, V. H., Hou, J., Beilhack, A., Zambricki, E. A., Buess, M., Contag, C. H., & Negrin, R. S. (2006) · Blood · doi:10.1182/blood-2006-07-038455 · Cited by 83
Baader, E., Toloczko, A., Fuchs, U., Schmid, I., Beltinger, C. P., Ehrhardt, H., Debatin, K., & Jeremias, I. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4278 · Cited by 82
Smac mimetics as IAP antagonists
Fulda, S. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.12.005 · Cited by 81
Jacob, N., Guo, S., Mathian, A., Koss, M. N., Gindea, S., Putterman, C., Jacob, C. O., & Stohl, W. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1000466 · Cited by 81
Karray, S., Kress, C., Cuvellier, S., Hue-Beauvais, C., Damotte, D., Babinet, C., & Lévi‐Strauss, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2118 · Cited by 79
GITR+ regulatory T cells in the treatment of autoimmune diseases
Petrillo, M. G., Ronchetti, S., Ricci, E., Alunno, A., Gerli, R., Nocentini, G., & Riccardi, C. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.10.011 · Cited by 79
Xiao, X., Shi, X., Fan, Y., Wu, C., Zhang, X., Minze, L. J., Liu, W., Ghobrial, R. M., Lan, P., & Li, X. C. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.013 · Cited by 79
Erratum: The role of CD95 and CD95 ligand in cancer
Peter, M. E., Hadji, A., Murmann, A. E., Brockway, S., Putzbach, W., Pattanayak, A., & Ceppi, P. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.25 · Cited by 79
Emerging Functions of RANKL in Lymphoid Tissues
Mueller, C. G., & Hess, E. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00261 · Cited by 78
Aspects of the tabby—crinkled—downless syndrome : I.The development of tabby teeth
Sofaer, J. A. (1969) · Development · doi:10.1242/dev.22.2.181 · Cited by 78
Myodegeneration in EDA-A2 Transgenic Mice Is Prevented by XEDAR Deficiency
Newton, K., French, D. M., Yan, M., Frantz, G. D., & Dixit, V. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.4.1608-1613.2004 · Cited by 77
Henley, T., Kövesdi, D., & Turner, M. (2008) · European Journal of Immunology · doi:10.1002/eji.200838618 · Cited by 77
The TNF-family cytokine TL1A: from lymphocyte costimulator to disease co-conspirator
Richard, A. C., Ferdinand, J. R., Meylan, F., Hayes, E. T., Gabay, O., & Siegel, R. M. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ri0315-095r · Cited by 76
RANKL/RANK: from bone loss to the prevention of breast cancer
Sigl, V., Jones, L. P., & Penninger, J. M. (2016) · Open Biology · doi:10.1098/rsob.160230 · Cited by 76
The Critical Role of LIGHT, a TNF Family Member, in T Cell Development
Wang, J. H., Chun, T., Lo, J. C., Wu, Q., Wang, Y., Foster, A., Roca, K., Chen, M., Tamada, K., Chen, L., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.5099 · Cited by 75
The Role of TL1A and DR3 in Autoimmune and Inflammatory Diseases
Aiba, Y., & Nakamura, M. (2013) · Mediators of Inflammation · doi:10.1155/2013/258164 · Cited by 73
Dohi, T., Borodovsky, A., Wu, P., Shearstone, J. R., Kawashima, R., Runkel, L., Rajman, L. A., Dong, X., Scott, M. L., Michaelson, J. S., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.11.017 · Cited by 73
Cachero, T. G., Schwartz, I. M., Qian, F., Day, E. S., Bossen, C., Ingold, K., Tardivel, A., Krushinskie, D., Eldredge, J. K., Silvian, L. F., et al. (2006) · Biochemistry · doi:10.1021/bi051685o · Cited by 72
The CD95/CD95L signaling pathway: A role in carcinogenesis
Fouqué, A., Debure, L., & Legembre, P. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.04.007 · Cited by 72
A Totally Sex-linked Gene in the House Mouse
Falconer, D. S. (1952) · Nature · doi:10.1038/169664b0 · Cited by 71
Perrier, C., Hertogh, G. D., Cremer, J., Vermeire, S., Rutgeerts, P. J., Assche, G. V., Szymkowski, D. E., & Ceuppens, J. L. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.23023 · Cited by 71
CD95 in cancer: tool or target?
Martín-Villalba, A., Llorens-Bobadilla, E., & Wollny, D. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.03.002 · Cited by 70
Cruz, A. C., Ramaswamy, M., Ouyang, C., Klebanoff, C. A., Sengupta, P., Yamamoto, T. N., Meylan, F., Thomas, S. K., Richoz, N., Eil, R. L., et al. (2016) · Nature Communications · doi:10.1038/ncomms13895 · Cited by 69
XEDAR as a putative colorectal tumor suppressor that mediates p53-regulated anoikis pathway
Tanikawa, C., Furukawa, Y., Yoshida, N., Arakawa, H., Nakamura, Y., & Matsuda, K. (2009) · Oncogene · doi:10.1038/onc.2009.154 · Cited by 68
The role of CD27 in anti-viral T-cell immunity
Grant, E. J., Nüssing, S., Sant, S. A., Clemens, E. B., & Kedzierska, K. (2017) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.12.001 · Cited by 68
Key facts and hot spots on tumor necrosis factor receptor‐associated periodic syndrome
Rigante, D., Lopalco, G., Vitale, A., Lucherini, O. M., Clemente, C. D., Caso, F., Emmi, G., Costa, L., Silvestri, E., Andreozzi, L., et al. (2014) · Clinical Rheumatology · doi:10.1007/s10067-014-2722-z · Cited by 67
Cited by
Atlas of the plasma proteome in health and disease in 53,026 adults
Deng, Y.-T., You, J., He, Y., Zhang, Y., Li, H.-Y., Wu, X.-R., Cheng, J.-Y., Guo, Y., Long, Z.-W., Chen, Y.-L., et al. (2025) · Cell · doi:10.1016/j.cell.2024.10.045 · Cited by 294
Tumor Necrosis Factor Receptors: Pleiotropic Signaling Complexes and Their Differential Effects
Gough, P., & Myles, I. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.585880 · Cited by 268
Cytokine and Chemokine Signals of T‐Cell Exclusion in Tumors
Zhang, Y., Guan, X.-Y., & Jiang, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.594609 · Cited by 133
Inflammatory Pathophysiology as a Contributor to Myeloproliferative Neoplasms
Fisher, D. A. C., Fowles, J. S., Zhou, A., & Oh, S. T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.683401 · Cited by 115
Krishnan, A., Ozturk, N. B., Cutshaw, K. A., Guicciardi, M. E., Kitagataya, T., Olson, K. E., Pavelko, K. D., Sherman, W., Wixom, A. Q., Jalan-Sakrikar, N., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-52710-3 · Cited by 8
Metadata
- Authors
- Dostert, C., Grusdat, M., Letellier, E., & Brenner, D.
- Venue
- Physiological Reviews
- Publisher
- American Physiological Society
- Published
- 2019-01-01
- Volume
- 99
- Issue
- 1
- Pages
- 115-160
- ISSN
- 0031-9333 (ISSN-L)
- 1522-1210
- OpenAlex
- W2898567584
- Cited by
- 498
- References
- 469
- FWCI
- 3.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.